Breg, Inc., a supplier of high-value sports medicine products and services based in Carlsbad, California, is expanding its offerings to China through a partnership with Coreal International.
Sports Med Company, Breg Expands to China
1 min read Premium comments
Secondary#breg#corealinternational
Founded in 2015, Coreal provides medical devices in China. The 50-employee company is owned by Shanghai-based Honrely Medical Products Co, Ltd. According to Coreal, the company supplies Class 1, 2, and 3 medical devices throughout China and represents such other Western Companies as Medtronic, B Braun, Johnson & Johnson and Olympus.”
Breg International Director of Sales Bianca Flikweert said, “China represents an exciting market for Breg, and Coreal is a strong partner, having just delivered 20% growth and record revenue in 2022.”
The partnership will allow Chinese physicians and patients to access Breg’s portfolio of products as early as spring, this year.
Breg offers a wide range of sports medicine and rehab products including bracing for knees, hips, shoulders, fracture repair, elbows, wrists, spine, feet, and ankles. In addition to bracing products, Breg also provides cold therapy products, canes, crutches, walkers, home therapy kits, pediatric products, and products for DVT prophylaxis.
Coreal CEO Steven Tao remarked, “We very much look forward to growing a strong footprint for Breg products in China.”
Tao continued, “To us, it is more than a partnership; it is a responsibility to build Breg’s reputation among physicians and patients so that they recognize Breg’s products can have a significant and meaningful impact on their lives.”
Founded in 1989, Breg is committed to providing orthopedic products to millions of patients every year. According to the press release, Breg is the “largest U.S. provider of cold therapy devices and second largest domestic provider of orthopedic bracing.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.